Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9651
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBate, Katherine Len
dc.contributor.authorJerums, Georgeen
dc.date.accessioned2015-05-15T22:49:30Z
dc.date.available2015-05-15T22:49:30Z
dc.date.issued2003-11-03en
dc.identifier.citationMedical Journal of Australia; 179(9): 498-503en
dc.identifier.govdoc14583083en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/9651en
dc.description.abstractDiabetes complications are common and almost triple the annual cost of managing diabetes. Microvascular complications are the major risk in type 1 diabetes, while macrovascular complications are the major cause of morbidity and mortality in type 2 diabetes. Control of hyperglycaemia (target HbA(1c) level < or = 7%) and hypertension (target blood pressure < or = 130/80 mmHg) prevents microvascular complications in both types of diabetes; a multifactorial approach, comprising behaviour modification and pharmacological therapy for all risk factors, reduces the development of micro- and macrovascular complications in type 2 diabetes. The benefit of treating dyslipidaemia is at least as great in the diabetic population as in the non-diabetic population. Angiotensin-converting enzyme inhibitors and low-dose aspirin are indicated in people with diabetes and other cardiovascular risk factors. Regular annual screening for diabetes complications allows treatable disease to be identified. Aggressive management of hyperglycaemia and other risk factors can prevent many complicationsen
dc.language.isoenen
dc.subject.otherAdulten
dc.subject.otherDiabetes Mellitus, Type 1.complicationsen
dc.subject.otherDiabetes Mellitus, Type 2.complicationsen
dc.subject.otherDiabetic Angiopathies.prevention & controlen
dc.subject.otherDiabetic Nephropathies.prevention & controlen
dc.subject.otherDiabetic Neuropathies.prevention & controlen
dc.subject.otherDiabetic Retinopathy.prevention & controlen
dc.subject.otherHemoglobin A, Glycosylated.analysisen
dc.subject.otherHumansen
dc.subject.otherHyperglycemia.therapyen
dc.subject.otherHyperlipidemias.therapyen
dc.subject.otherHypertension.drug therapyen
dc.subject.otherLife Styleen
dc.subject.otherRisk Factorsen
dc.title3: Preventing complications of diabetes.en
dc.typeJournal Articleen
dc.identifier.journaltitleMedical Journal of Australiaen
dc.identifier.affiliationkbate@smartchat.net.auen
dc.identifier.affiliationEndocrinology Unit, Austin Health, Studley Road, Heidelberg, VIC 3084, Australiaen
dc.description.pages498-503en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/14583083en
dc.type.austinJournal Articleen
local.name.researcherJerums, George
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

40
checked on Nov 1, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.